Informações:
Falhas:
ID
14484
Descrição
A Comparison of Symbicort® Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma; ODM derived from: https://clinicaltrials.gov/show/NCT00628758
Link
https://clinicaltrials.gov/show/NCT00628758
Palavras-chave
Versões (1)
- 18/04/2016 18/04/2016 -
Titular dos direitos
CC BY-NC 3.0
Transferido a
18 de abril de 2016
DOI
Para um pedido faça login.
Licença
Creative Commons BY-NC 3.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Asthma NCT00628758
Eligibility Asthma NCT00628758
- StudyEvent: Eligibility
Similar models
Eligibility Asthma NCT00628758
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
informed consent form
Item
signed informed consent form. if the patient cannot read and write, verbal consent from the patient is required.
boolean
C0021430 (UMLS CUI [1])
turkish literacy
Item
ability to read and write in turkish
boolean
C0023864 (UMLS CUI [1,1])
C0041402 (UMLS CUI [1,2])
C0041402 (UMLS CUI [1,2])
outpatients aged 18 years
Item
female or male outpatients aged 18 years
boolean
C0001779 (UMLS CUI [1])
C0029921 (UMLS CUI [2])
C0029921 (UMLS CUI [2])
history of asthma
Item
minimum of 3 months history of asthma, diagnosed according to the american thoracic society (ats) definition
boolean
C0262926 (UMLS CUI [1,1])
C0004096 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,3])
C0004096 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,3])
ics
Item
prescribed inhaled glucocorticosteroid (gcs) at a dose of 320mg/day and within the approved label for the relevant drug during the last 3 months prior to visit 1
boolean
C3248292 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,2])
asthma treatment
Item
either: daily maintenance treatment with both inhaled gcs and long-acting b2-agonist (laba) or daily treatment with inhaled gcs alone (i.e. without laba); and a history of suboptimal asthma control the month prior to enrollment as judged by the investigator; and use of 3 peak expiratory flow inhalations ofas needed medication for symptom relief during the last 7 days before enrollment
boolean
C2065041 (UMLS CUI [1])
C0040223 (UMLS CUI [2])
C1373132 (UMLS CUI [3])
C0040223 (UMLS CUI [2])
C1373132 (UMLS CUI [3])
symbicort
Item
previous treatment with symbicort single inhaler therapy
boolean
C1121854 (UMLS CUI [1,1])
C1514463 (UMLS CUI [1,2])
C1514463 (UMLS CUI [1,2])
adrenergic beta-antagonists
Item
use of any b-blocking agent, including eye drops
boolean
C0001645 (UMLS CUI [1])
oral corticosteroid
Item
use of oral gcs as maintenance treatment
boolean
C0001617 (UMLS CUI [1])
hypersensitivity to study therapy or excipients
Item
known or suspected hypersensitivity to study therapy or excipients
boolean
C0020517 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,2])
smoking history
Item
a history of smoking 10 pack years
boolean
C1519384 (UMLS CUI [1])
C1277691 (UMLS CUI [2])
C1277691 (UMLS CUI [2])
pregnancy lactation intention to become pregnant
Item
pregnancy, breast-feeding or planned pregnancy during the study. fertile women not using acceptable contraceptive measures, as judged by the investigator
boolean
C0032961 (UMLS CUI [1])
C3831118 (UMLS CUI [2])
C0700589 (UMLS CUI [3])
C0006147 (UMLS CUI [4])
C0032961 (UMLS CUI [5,1])
C1283828 (UMLS CUI [5,2])
C3831118 (UMLS CUI [2])
C0700589 (UMLS CUI [3])
C0006147 (UMLS CUI [4])
C0032961 (UMLS CUI [5,1])
C1283828 (UMLS CUI [5,2])
comorbidity limiting participation
Item
any significant disease or disorder, which, in the opinion of the investigator, may put the patient at risk because of participating in the study
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])